2010•Practical Journal of Cardiac Cerebral Pneumal and Vascular DiseaseRequires access
Clinical Investigation on Cefoperazone/Sulbactam and Azithromycin in the Treatment of Community-Acquired Pneumonia
Huang Yun-pin
Open publisher page 0 citations
Abstract
Objective To evaluate the efficacy and safety of cefoperazone/sulbactam and azithromycin in the treatment of community-acquired pneumonia(CAP).Methods 48 patients with CAP were randomly divided into two groups:treatment group:the patients were treated with cefoperazone/sulbactam and azithromycin,control group:the patients were treated with cefoperazone/sulbactam alone.Both groups were treated for 7～14 days.Efficacy and safety of cefoperazone/sulbactam and azithromycin in the treatment were observed.Results The overall efficacy was 95.83% for the treatment group and 83.33% for control group.The results showed that there were significant differences between the two groups(P0.05);The rates of the side effects were 12.50% and 8.33%,respectively.There were no significant differences between the two groups(P0.05).Conclusion Cefoperazone/sulbactam and azithromycin in the treatment of community-acquired pneumonia(CAP) can improve efficacy,shorten the course of disease and are well tolerated.